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Congenital heart disease (CHD) is the most common class of human birth defects, with a
prevalence of 0.9% of births. However, two-thirds of cases have an unknown cause, and
many of these are thought to be caused by in utero exposure to environmental teratogens.
Here we identify a potential teratogen causing CHD in mice: maternal iron deficiency (ID).
We show that maternal ID in mice causes severe cardiovascular defects in the offspring.
These defects likely arise from increased retinoic acid signalling in ID embryos. The defects
can be prevented by iron administration in early pregnancy. It has also been proposed that
teratogen exposure may potentiate the effects of genetic predisposition to CHD through
gene–environment interaction. Here we show that maternal ID increases the severity of heart
and craniofacial defects in a mouse model of Down syndrome. It will be important to
understand if the effects of maternal ID seen here in mice may have clinical implications
for women.
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Congenital heart disease (CHD) is the most common classof birth defects, with a global prevalence of 0.9% of livebirths1. It is a major cause of infant mortality and mor-
bidity, and requires ongoing medical treatment throughout life.
CHD results from defects occurring early in the development of
the embryo, either because of gene mutation, chromosomal
abnormality or the impact of environmental factors. Most
research in the last 30 years has focused on genetic causes of
CHD. However, despite the association of over 100 genes with
CHD, mutations in these genes only explain ~30% of cases2.
Many of the remaining cases of CHD are caused by in utero
exposure to environmental factors3. Although the teratogenicity
of a wide variety of such factors has been known since the 1940s,
very little is known about how these factors perturb embryonic
development at the molecular level.
In the past 20 years, several populations of cardiac progenitor
cells have been identified, and the molecular events driving heart
formation in the mammalian embryo have been described in
great detail4. This knowledge now provides a scaffold for
understanding how environmental factors cause CHD. For
example, we and others have described at the molecular level in
mice how maternal exposure to hypoxia during gestation5 or
pharmacological activation of HIF1 signalling6 causes the most
common subtype of CHD, cardiac outflow tract (OFT) defects.
However, these hypoxia studies were done in animal models and
do not replicate any particular clinical condition, and it is
therefore uncertain how relevant these findings are to human
populations.
One way in which embryonic hypoxia might occur clinically is
through maternal or embryonic anaemia. This is a major global
health problem, affecting 20–40% of women of child-bearing age,
a total of more than 500 million individuals7. Maternal anaemia
in rabbits8 and maternal iron deficiency (ID) in rats9 can result in
embryonic lethality, but the molecular mechanisms are unknown.
In humans, at least half of all cases of anaemia result from ID7.
Furthermore, low iron intake during pregnancy in humans may
increase the risk of intrauterine growth restriction10 and CHD11.
In this study, we use a mouse model to investigate how
maternal ID affects embryonic development. We show that
maternal ID causes severe cardiovascular defects in her offspring.
These defects arise from premature differentiation of a subset of
cardiac progenitor cells. This effect is likely caused by increased
retinoic acid signalling in ID embryos. This is a distinct
mechanism to that we previously showed for hypoxia. The defects
can be prevented by maternal iron administration early in preg-
nancy. In addition, they are greatly reduced in offspring of
mothers deficient in both iron and the retinoic acid precursor
vitamin A; and largely eliminated by mid-gestation administra-
tion of an inhibitor of RA signalling, supporting our hypothesis
that retinoic acid signalling is elevated in these embryos. Finally,
one puzzling feature of many genetic forms of CHD in humans is
the considerable variation in penetrance and severity of defects. It
has been hypothesised that such variation may be caused by
gene–environment interactions. In support of this hypothesis, we
show a strong gene–environment interaction in a mouse model of
Down syndrome.
Results
Maternal iron deficiency perturbs embryonic development. We
used our previously published model12 to investigate the effects of
maternal ID on embryonic development. Female C7BL/6 J strain
mice were weaned onto, and maintained continuously on, a low
iron diet (2–6 ppm). At maturity, these mice had significantly
reduced blood haemoglobin (P < 0.0001, Supplementary Fig. 1a)
and liver iron levels (Fe56 concentration P= 0.005, Perls staining
P < 0.0001, Supplementary Fig. 1b–e) compared to females fed a
standard diet (200 ppm iron). The range of blood haemoglobin
levels observed (20–105 g/l) is comparable to those observed in
mild-to-severe anaemia in humans as defined by the World
Health Organisation (WHO)13. ID females were mated to iron-
replete C57BL/6 J males, then maintained on the low iron diet
until embryo collection on E15.5. ID embryo morphology was
compared to that of embryos from control mothers (Fig. 1a, b).
Microscopic Magnetic Resonance Imaging (µMRI) showed that
E15.5 embryos had significantly reduced liver iron levels (P <
0.0001, Supplementary Fig. 1f–h). Macroscopic observation at
dissection revealed that 12/80 ID embryos had died recently (0/58
controls, P= 0.0010) and 26/68 of the surviving ID embryos had
significant subcutaneous oedema (0/58 controls, P < 0.0001).To
determine the developmental progression of these phenotypes, we
examined ID embryos between E9.5 and E14.5 (Fig. 1c). Oedema
and recent death were observed in a significant number of
embryos from E12.5 onwards, with a peak at E13.5 (P= 0.0008 vs
E12.5 and P= 0.0078 vs E15.5). We conclude that maternal ID
severely perturbs embryonic development in mouse.
ID embryos have cardiovascular defects. We hypothesised that
maternal anaemia causes embryonic hypoxia, which we have
previously shown leads to a variety of embryonic defects, most
notably in the cardiovascular system5. We therefore examined
cardiac morphology in surviving ID embryos at E15.5 (Fig. 1d–g,
Supplementary Table 1). In total, 30/42 of these embryos had
heart defects (1/37 controls, P < 0.0001). Membranous and
muscular ventricular septal defects (VSDs) were most common
(Fig. 1e, f), occasionally coupled with double-outlet right ventricle
(DORV) or overriding aorta (OA). Finally, 5/42 embryos had
atrioventricular septal defects (AVSD, Fig. 1g, yellow arrow)
compared to 0/37 controls (P= 0.0377). In addition, the ven-
tricular myocardium was significantly thinner in all ID embryos
(Fig. 1e–g, black arrowheads; quantified in Supplementary Fig. 2a,
P < 0.0001), and in some embryos the ventricular septum (VS)
was non-compacted (Fig. 1f, g, yellow arrowheads). The same
phenotypes were seen in 7/9 surviving pups analysed at P0,
suggesting that it is unlikely that the cardiac defects are simply
due to delays in cardiac development.
We next investigated whether there was increased penetrance
of abnormal heart phenotype in litters from more severely
anaemic dams. The 42 embryos assessed for heart morphology
were derived from seven litters. Four dams had haemoglobin
levels <80 g/l (equivalent to moderate-severe anaemia in humans)
and three dams had ~100 g/l (below the control mean of 132.6 g/l,
and equivalent to mild anaemia in pregnant humans). Embryos
from dams with <80 g/l had a significantly higher rate of heart
defects (19/22) compared to embryos from dams with ~100 g/l
(11/20, P= 0.0276, one-tailed Fisher’s exact test). Both groups
had a significantly increased rate of heart defects to control
embryos (P < 0.0001, one-tailed Fisher’s exact test).
To investigate the developmental origins of the heart defects,
we measured OFT physical parameters at E10.5 using 3D
volume-rendered high resolution episcopic microscopy (HREM)
datasets (Supplementary Fig. 2b, c). Because OFT morphology
changes rapidly, we matched embryos by Theiler stage (TS). In
control embryos, distal OFT length increased from TS16
(30–34 somites) to TS18 (40–44 somites), whilst the angle
between distal and proximal OFT decreased. By contrast, at TS16
ID embryos had a significantly shorter distal OFT (P= 0.0295,
Supplementary Fig. 2b), and by TS18, they had a significantly
larger distal/proximal OFT angle than controls (P= 0.0109,
Supplementary Fig. 2c). These observations are similar to mouse
models of CHD caused by a reduced contribution of second heart
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field (SHF) cardiac progenitor cells to the OFT, including Tbx1,
Hes1 and Hoxb1 null embryos, and embryos exposed to hypoxia
in utero5,14–16. In these studies, reduced OFT length is proposed
to cause malrotation and malalignment of the OFT at later
developmental stages. In keeping with this hypothesis, by E12.5 4/
8 ID embryos had a non-rotated OFT based on cardiac cushion
position (Fig. 1k), 2/8 were partially rotated (Fig. 1j) whilst 2/8
were normal (Fig. 1i), compared to 9/9 control embryos with
normal OFT rotation (Fig. 1h, P= 0.0023) . The non-rotated
OFTs in ID embryos resembled those of control E11.5 embryos
(Fig. 1l).
We also found both OFT and atrio-ventricular (AV) cardiac
cushions were abnormal at E12.5. The cardiac cushions are the
precursors of the valves and septa17. The OFT cushions form the
aortic valve (AoV), pulmonary valve (PV) and the spiral septum
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are also required for the final closure of the tertiary ventricular
foramen in the ventricular septum required to functionally
separate the left and right ventricles19. The AV cushions
contribute to the AV valves, as well the atrial and ventricular
septa. In the OFT, the two major cushions are elongated and
spiral around the OFT. In between the major cushions are two
smaller ridges, called intercalating cushions (ICC) or intercalated
valve swellings. By E12.5, the major cushions fuse to form the
aortico-pulmonary septum as well as the right and left coronary
cusps of the AoV and the right and left cusps of the PV. The ICC
do not fuse: the aortic ICC forms the non-coronary (NC) leaflet
of the AoV, and the pulmonary ICC forms the non-facing (NF)
leaflet of the PV. At E12.5, proximal OFT cushion fusion had not
occurred in 8/8 ID embryos (Fig. 1i–k white arrows), compared to
2/9 controls (P= 0.0019). This was not likely to be due to
generalised developmental delay, since ventricular volumes were
not significantly different in ID embryos (P= 0.0521, Supple-
mentary Fig. 2d), and the appearance of limb morphology and
somite number was comparable between E12.5 ID and control
embryos. Furthermore, by E13.5, the proximal OFT cushions
were still not fused in 5/5 ID embryos (0/5 controls, P= 0.0040).
Concomitant with the morphological differences in the OFT at
E12.5, the right OFT cushion (P= 0.0101) and aortic ICC (P <
0.001) were significantly smaller in ID embryos (Supplementary
Fig. 2f–h), although the left OFT cushion (P= 0.3679) and
pulmonary ICC (P= 0.0650) were not significantly changed
(Supplementary Fig. 2e). The aortic ICC was more affected, being
only 25% of normal volume, whilst right OFT cushion was 70%
normal size.
AV cushion formation was also abnormal in ID embryos.
There are four AV cushions. The large inferior and superior
cushions contribute to the atrial and ventricular septa, the aortic
leaflet of the mitral valve (MV) and the septal leaflet of the
tricuspid valve (TV). The smaller right lateral cushion forms the
anterior and posterior leaflets of the TV, and the left lateral
cushion forms the mural leaflet of the MV. At E12.5, the superior
and inferior AV cushion volumes were the same between control
and ID embryos (Supplementary Fig. 2i, j). However, the left and
right lateral AV cushions were completely absent from 3/8 ID
embryos (Fig. 1p; 0/9 controls, P= 0.0824), although there was
no significant difference in volume between extant lateral
cushions in ID embryos and controls (left P= 0.4820, right P
= 0.3636, Supplementary Fig. 2k, l). These cushions were also
absent in 3/3 E11.5 control embryos (Fig. 1q), suggesting that this
might be due to delayed development. In addition, the inferior
and superior cushions were not apposed in 4/8 ID embryos at
E12.5, when fusion is normally complete (Fig. 1o, p; yellow
arrows; 0/9 controls, P= 0.0294). These cushions were still not
touching in 3/5 E13.5 ID embryos, suggesting a persistent defect
rather than a developmental delay. The presence or absence of
AV cushion contact did not correlate well with the extent of OFT
rotation, as 3/5 embryos with the most severe OFT rotation defect
(Fig. 1k) had normal AV cushion contact, and 2/2 embryos with
milder OFT rotation defects (Fig. 1j) had non-touching AV
cushions. In normal development, as the aortic root shifts from
over the right ventricle to its final position over the left ventricle,
the fused proximal OFT cushions align with the growing tip of
the muscular VS18,20. The remaining interventricular commu-
nication is then closed at E14.5 by the membranous VS that forms
by fusion of the rightward tips of the AV cushions with the
proximal OFT cushions21. Delayed or failed proximal cushion
fusion, or incomplete shifting of the aortic root, will result in
VSD, OA and DORV; and failed OFT-AV cushion fusion will
prevent membranous VS formation and can contribute to
AVSD20. Thus, the cardiac defects observed at E15.5 in ID
embryos are likely to arise from the OFT and AV cushion defects
observed at E12.5.
Clinically, cardiac OFT defects commonly occur in conjunction
with aortic arch (AA) anomalies. Typically, such defects originate
from a failure of pharyngeal arch artery (PAA) formation or
remodelling from E9.5. During normal development, the first
three pairs of PAA form prior to TS1622. By TS16, the fourth pair
appears, whilst the first two pairs regress, and no longer connect
to the dorsal aorta (Fig. 2a). The sixth pair develops by TS18, thus
at this stage there are symmetrical arteries in the third, fourth and
sixth pharyngeal arches (Fig. 2c). At TS16, whilst all ID embryos
had fully patent PAA3, 5/12 ID embryos had bilaterally absent
PAA4 (Fig. 2b) and in the remainder, PAA4 was only partially
formed on both sides, compared to 7/7 controls with fully patent
PAA3-4, (P < 0.0001). In addition, in 8/12 embryos the second
PAA was still connected to the dorsal aorta (seven bilaterally and
one unilaterally; Fig. 2b’, black arrow), compared to 1/7 controls
(Fig. 2a, b; P= 0.0399). By TS18, whilst all ID embryos had
patent PAA3, 2/7 had absent or interrupted PAA4 (one bilateral
and one unilateral) and 3/7 had absent or interrupted PAA6 (two
bilateral and one unilateral; Fig. 2d, white arrows; 6/6 controls
with fully patent PAA3-6; P= 0.1224). In addition, 4/7 ID
embryos had bilaterally hyperplastic PAA2, with one of these still
patent with the dorsal aorta (0/6 controls, P= 0.0490). This
suggests that PAA development was delayed and abnormal.
Indeed, at E12.5, 8/8 ID embryos had persistent right dorsal aorta
(Fig. 2f, orange arrow, 0/9 controls, P < 0.0001). Unexpectedly, by
E15.5 only 5/40 ID embryos had AA anomalies (Supplementary
Table 2, 1/37 controls, P= 0.1189). These included interrupted
AA (IAA), aberrant right subclavian artery (A-RSA, Fig. 2h,
yellow arrow), right-sided AA and retroesophageal left subclavian
artery (R-LCC, associated with right-sided AA). A similar
decrease in the penetrance of AA anomalies between E10.5 and
foetal stages has been observed in mouse knockout models23,24.
This might result from increased lethality of embryos with
Fig. 1 Maternal ID causes embryonic defects and lethality. a, b Embryos from ID mothers have gross sub-cutaneous oedema. Representative images of
control (a) and ID (b) E15.5 embryos. Black arrows indicate subcutaneous oedema. c Histograms of a developmental time-course showing significant
embryonic lethality from E12.5. d–g Representative frontal H&E sections of hearts from control (d) and ID (e–g) E15.5 embryos. VSD (black arrows), AVSD
(yellow arrow), thin ventricular myocardium (black arrowheads) and disorganised ventricular septum (yellow arrowheads) are indicated. Relative incidence
of each phenotype in all hearts analysed by µMRI, HREM and paraffin sectioning are indicated. h–q Abnormal cushion formation in E12.5 ID embryos. h–l
Representative 3D Amira reconstructions of OFT cushions from manually segmented HREM data showing dorsal (h–l) and ventral (h’–l’) views of (h) E12.5
control embryo, (i) normally rotated OFT from E12.5 ID embryo, (j) partially rotated OFT from E12.5 ID embryo, (k) non-rotated OFT from E12.5 ID embryo,
(l) E11.5 control embryo. The left OFT cushion (yellow), right OFT cushion (green), aortic ICC (pink) and pulmonary ICC (blue) are shown. White arrows
indicate unfused proximal cushions. m–q 3D reconstructions of the AV cushions showing dorsal (m–q) and ventral (m’–q’) views from the same embryos.
The superior AV cushion (red), inferior AV cushion (cyan), left lateral AV cushion (orange) and right lateral AV cushion (purple) are shown. Yellow arrows
indicate non-touching AV cushions. Statistical significance was tested using one-sided Fisher’s exact test (panel c). P values: E9.5 0.0143; E10.5 0.1735;
E11.5 0.7273; E12.5 < 0.0001; E13.5 < 0.0001; E14.5 < 0.0001; E15.5 < 0.0001. ns not significant, *P < 0.05, ****P < 0.0001. Scale bar= 2mm (a, b) and
200 µm (d–g).
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abnormal AA formation prior to E15.5, or there may be
compensatory mechanisms allowing phenotypic recovery. The
phenotypes observed at E15.5 are typical of a failure of PAA4
formation25. Therefore, the aortic arch defects in ID embryos are
likely to arise from the observed perturbation of PAA4 formation
earlier in development.
Maternal ID causes premature differentiation of SHF cardiac
progenitor cells. We next investigated the developmental origin
of the cardiovascular defects. Four different cell lineages con-
tribute to OFT cardiac cushion formation: endocardium, second
heart field (SHF), cardiac neural crest (CNC) and epicardium17.
Each particular cushion contains a characteristic combination of
cells derived from a subset of these lineages. The aortic ICC was
most severely effected in ID embryos (Supplementary Fig. 2g).
This cushion is predominantly composed of SHF-derived
cells26–28, suggesting that the reduction in cushion size might
be due to a lack of this cell type. A variety of mouse knockout
models with cardiac OFT defects have a deficit of anterior SHF
cells. This can arise by a variety of processes, including premature
differentiation29, disruption of proliferation5,30,31 or inhibited
migration32.
To investigate if any of these mechanisms were also occurring
in ID embryos, we compared the transcriptomes of aSHF cells
from ID and control embryos. We also compared these data with
the transcriptome of aSHF cells from embryos exposed to hypoxia
in utero, the molecular effects of which we have previously
described5. ID and control female C57BL/6 J mice were mated
with hemizygous Mef2c-AHF-GFP males33. This allele directly
drives GFP expression from the Mef2c-AHF enhancer element,
specifically marking cells strongly in the aSHF and weakly in the
distal OFT (Fig. 3a). For control and ID samples, embryos were
collected at E9.5. For hypoxia samples, pregnant mice were
exposed to an atmosphere containing 6% oxygen for 4 hours on
E9.5, and embryos collected immediately after exposure. RNA
was isolated from GFP+ cells from five individual somite-
matched embryos for each condition and RNA sequencing
(RNA-Seq) was performed. Unsupervised hierarchical clustering
correctly grouped samples (Fig. 3b). As expected from our
previous study5, differential expression (DE) analysis showed that
aSHF cells from hypoxic embryos had increased expression of
unfolded protein response (UPR) genes and spliced Xbp1
transcript; elevated transcript levels of hypoxia-response genes
(including those involved in metabolism, angiogenesis and
pathway regulation); increased expression of cell cycle inhibitors;
decreased expression of cell-cycle progression genes; but no
induction of apoptotic HIF1 targets (Fig. 3d). By contrast, aSHF
cells from ID embryos did not activate UPR response genes or
HIF1 targets, nor was cell-cycle gene expression altered. Overall,
there was very little overlap in the significantly DE genes between
ID and hypoxia samples (Fig. 3c). Together, these observations
suggest that iron deficiency and hypoxia act via distinct
mechanisms to cause heart defects.
We used gene ontology (GO) analysis with the GSEA online
resource34,35 to provide an unbiased assessment of significantly
altered pathways. As expected, the top upregulated gene set in the
hypoxia samples was Hallmark_hypoxia (P= 5.33 × 10−55), and
the top downregulated gene set was Hallmark_mitotic_spindle
(P= 7.66 × 10−10). By contrast, the most enriched gene set in the
ID model was Hallmark_myogenesis (P= 4.65 × 10−17). Further
analysis of the ID dataset revealed that expression of multiple
markers of cardiac OFT differentiation were substantially
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Fig. 2 Maternal ID causes aortic arch abnormalities. Comparison of aortic arch artery morphology between control (a, c, e, g) and ID (b, d, f, h) embryos.
Representative 3D Amira reconstructions from manually segmented HREM data of early E10.5 (a, b), late E10.5 (c, d), E12.5 (e, f) and E15.5 (g, h) embryos.
For clarity of PAA identity, 3D models of E10.5 embryos are overlaid onto a sagittal section of the same embryo (a’–d’). Persistent PAA2 (panel b’, black
arrow), interrupted PAA4 and PAA6 (panel d, white arrows), persistent right dorsal aorta (panel f, orange arrow) and aberrant right subclavian artery
(panel h, yellow arrow) are indicated. da dorsal aorta, oft outflow tract, ao aorta, pt pulmonary trunk, rsa right subclavian artery, rcc right common carotid
artery, lcc left common carotid artery, lsa left subclavian artery, ad arterial duct.
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DE transcripts from ID embryos with data from single cell
transcriptomic analysis of the cardiogenic regions of E9.25
embryos36. The ID transcriptome was most closely related to the
OFT cluster, rather than to the aSHF cluster (P= 3.5798 × 10−6,
Fig. 3e).
Premature differentiation of the aSHF is a feature of several
mouse knockout models with similar cardiac defects to our ID
model, including Tbx1 null29,37 and Hoxb1 null16 embryos. In
these models, premature differentiation of aSHF cells at E9.5
causes similar phenotypes to ID, namely defective OFT elonga-
tion, alignment and septation, resulting in a specific set of cardiac
defects by E15.5, including membranous VSDs (with or without
DORV or OA), transposition of the great arteries (TGA) and
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validated the presence of premature differentiation in the SHF by
examining protein expression levels and pattern of the myocyte
differentiation marker MHC (Fig. 4a–e). MHC expression is
normally restricted to the wall of the OFT, with no expression in
the contiguous cells of the aSHF (Fig. 4a). By contrast, in ID
embryos ectopic MHC expression extended into the aSHF
(Fig. 4b, d), and a significantly larger number of aSHF cells
expressed MHC (P < 0.0001, Fig. 4e). Similar defects can be
caused by reduced cell proliferation38,39 in the SHF. However,
there was no significant difference in the percentage of
phosphorylated histone H3-positive nuclei between ID and
control SHF cells (P= 0.3438, Supplementary Fig. 3a, b, d).
The cardiac transcription factor GATA4 is a key regulator that
promotes the switch from proliferation to differentiation in SHF
cells29. Gata4 transcripts were substantially increased in the ID
aSHF transcriptome (Fig. 3d), and GATA4 protein and transcript
levels were elevated in the OFT and ectopically expressed in the
aSHF of ID embryos at E9.5 (Fig. 4f–I, Supplementary Fig. 3e, f).
By contrast, the expression levels and domain of TBX5 protein, a
marker of the posterior SHF, were unchanged (Supplementary
Fig. 3g–i). GATA4 directly activates the transcription of many
cardiac differentiation genes and transcription factors, including
MHC40. Many of these direct GATA4 targets were also
substantially upregulated in the ID aSHF transcriptome (Fig. 3d).
In Tbx1 null embryos, Gata4 expression is elevated, and SHF cells
prematurely differentiate29. Thus, it is likely that the cardiovas-
cular defects in the ID embryos result from premature
differentiation of aSHF cells, which then fail to migrate into the
OFT, OFT cushions and aortic arches.
Embryos show perturbed retinoic acid signalling. The cardio-
vascular defects observed in ID embryos resemble those present
in mouse or chick embryos with excess retinoic acid (RA)
signalling41–43, after exposure to excess vitamin A44, or in
humans exposed to the drug isotretinoin45. In mouse embryos,
RA signalling is mediated by all-trans retinoic acid (ATRA). This
compound is synthesised from vitamin A, and can be subse-
quently catabolised to the biologically inactive compound 4-
hydroxy ATRA by the CYP26 family of cytochrome P450
enzymes. The active site of CYP26 enzymes incorporates haem,
so we hypothesised that RA catabolism might be reduced in ID
embryos, resulting in excess RA signalling. Supporting this
hypothesis, E15.5 Cyp26b1 null mouse embryos have a similar
spectrum of heart defects to ID embryos, including membranous
VSDs (frequently coupled with DORV or OA), partial AVSDs
and AA anomalies (C. Roberts, personal communication). In
addition, Gata4 transcription is directly activated by RA
signalling46,47, thus this might also explain the ectopic upregu-
lation of Gata4 in ID embryos.
To test this hypothesis, we examined the level of RA signalling
in ID embryos using the RARE-LacZ transgenic reporter48. Males
carrying the RARE-LacZ allele were crossed with control or ID
C57BL/6 J females, embryos collected at E9.5, and stained for ß-
GALACTOSIDASE activity with X-gal. In control embryos at
E9.5, ß-GALACTOSIDASE activity was present in paraxial
mesoderm, SHF, OFT and brain, as previously described48. ID
embryos had a broadly similar expression pattern, however X-gal
staining developed more rapidly, suggesting higher levels of RA
signalling in ID embryos. Sections from somite-matched embryos
dissected on the same day and stained for the same time
confirmed that ID embryos had stronger OFT expression than
controls (Fig. 4j, k). In addition, expression was patchy in ID
embryos (Fig. 4k, arrows) and was also present in the ventricle
(Fig. 4k, arrowhead). Two-channel HREM of X-gal-stained E9.5
embryos coupled with 3D reconstruction in Amira was used
better visualise the 3D pattern of RA expression in the OFT
(Fig. 4l, m). This shows that RA signalling levels were present in a
larger domain of the OFT. We confirmed the changes in ß-
GALACTOSIDASE protein expression in the OFT using
immunofluorescence (Fig. 4n, o, q). Finally, to confirm that RA
signalling directly regulates Gata4 transcription, we examined
published ChIP-seq data and identified a putative RA-responsive
enhancer in the first intron of the mouse Gata4 gene
(Supplementary Fig. 4). In cardiomyocytes derived from
differentiated mouse ESC, H3K27ac marks a region that is
flanked by two consensus RAR/RXR binding sites49. These sites
bind RARA and RXRA in in response to RA-induced
differentiation of F9 embryo carcinoma cells50.
These data suggest that ID embryos have increased RA
signalling in the SHF and OFT, directly causing ectopic activation
of Gata4 in the SHF and initiating premature differentiation of
these cells.
Other embryonic processes dependent on RA signalling are
perturbed in ID embryos. In addition to cardiovascular devel-
opment, RA signalling has many other roles throughout
embryonic development51. To determine if ID causes a more
general upregulation of RA signalling in the developing embryo,
we investigated if the development of any other RA-dependent
systems were also perturbed. We first investigated the origins of
the subcutaneous oedema observed at E15.5. This is a relatively
common phenotype in embryonic lethal and sub-viable knockout
mouse models. For example, in an unbiased survey of embryonic
lethal mouse strains, 24/42 had subcutaneous oedema at E14.552.
In humans, this phenotype is called hydrops fetalis and can arise
from embryonic anaemia or cardiovascular defects, resulting in
cardiac failure and a generalised fluid build-up53. In our study, we
assessed 42 ID E15.5 embryos for both oedema and heart defects.
26 were concordant and 16 discordant, thus there was no cor-
relation between the presence of oedema and heart defects (P <
0.0001).
Fig. 3 Transcriptomic analysis of anterior SHF cells. a Representative E9.5 embryo showing the expression domain of the Mef2c-AHF-GFP transgene
(n= 5). Scale bar is 500 µm. b Unsupervised hierarchical clustering using normalised gene expression levels ordered samples into the correct condition
groups. Only differentially expressed genes are shown with adjusted p value < 0.01, B > 1 and differentially expressed < >2-fold. c Comparison of genes
differentially expressed relative to control samples shows little overlap between ID and hypoxia samples. Analysis was restricted to genes with adjusted
p value < 0.01, B > 1 and differentially expressed < >2-fold. d Comparison of expression changes relative to control samples of ID and hypoxia samples. Heat
maps show the average fold-change between ID or hypoxia and control samples of selected genes involved in the hypoxia response, the unfolded protein
response, cell cycle control, cardiac muscle proteins and GATA4 direct targets. e The ID transcriptome is more closely related to the OFT cluster than the
aSHF cluster from single-cell RNA-Seq of heart and cardiac progenitor cells at E9.25 (de Soysa et al.36). Heat maps show every gene in each de Soysa
cluster with significant (P < 0.05) fold-change between ID and control samples. Statistical significance was tested using a hypergeometric test (assuming
20,000 genes in the transcriptome) with Bonferroni correction to control the familywise error rate. P values: OFT 3.5798 × 10−6; RV 3.2923 × 10−4; aSHF
3.5365 × 10−4; pSHF 1.8708 × 10−3; LV 1.0542 × 10−2. aSHF anterior second heart field, pSHF posterior second heart field, OFT outflow tract, RV right
ventricle, LV left ventricle.
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Alternatively, oedema can be caused by a failure of normal
lymphatic development. This process requires RA signalling, and
genetic knockout of Cyp26b1 results in an identical phenotype to
that observed in ID embryos42. Therefore, we investigated
whether lymphatic development was compromised in ID
embryos. The blood and lymphatic vasculature were visualised
in E14.5 dorsal back skin using CD31, PROX1 and NRP2
antibodies54 (Fig. 5a, b). Lymphatic vessels in ID embryos had
significantly increased in vessel diameter (P= 0.0006, Fig. 5c) and
the vessels had more PROX1-positive nuclei (compare Fig. 5
panels a” and b”). The degree of increase in lymphatic vessel
diameter (33 to >52 μm) was similar to other mouse models with
perturbed lymphatic development42,55. By contrast, inter-vessel
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were there changes in the patterning of the blood vasculature
(Fig. 5a”’, b”’).
These data suggest that the changes in lymphatic vasculature
may be due to a primary defect in lymphatic development, rather
than to increased dilation of the vessels subsequent to cardiac
failure. In control E11.5 embryos, RA signalling is activated
between the dorsal aorta and the ventro-medial side of the
cardinal vein (Bowles et al.;22 Fig. 5e, f). This is on the opposite
wall of the cardinal vein from where lymphatic endothelial cell
(LEC) progenitors arise. In ID embryos, RA signalling was
increased and expanded dorsally (Fig. 5g, h). This is indis-
tinguishable from the phenotypes observed in Cyp26b1 null
embryos, where RA signalling is also increased42.
We next examined the development of the coronary vascu-
lature. This develops through a stepwise vasculogenic pro-
gramme. Firstly, an immature vessel plexus forms, and then
this is remodelled into a mature vascular bed56. The coronary
endothelial progenitors arise mostly from the sinus venosus (SV)
and the endocardium57. The epicardium, a layer of cells that
migrates over the heart surface from E9.0, is also required for
coronary vascular development58. It secretes trophic factors,
including RA, that stimulate myocardial growth and coronary
plexus development. It also contains epicardial-derived progeni-
tor cells (EPDCs) that give rise to cardiac fibroblasts and vascular
smooth muscle cells (VSMC) that stabilise the coronary
vasculature. EPDCs also contribute to the lateral AV cushions59,
which were missing in some ID embryos (Fig. 1p). In total, 8/8
control hearts at E14.5 had normal coronary plexus formation on
both dorsal and ventral surfaces (Fig. 5i, k). By contrast, 8/8 ID
hearts showed a reduced plexus area, and large numbers of
endothelial nodules were present on both heart surfaces (Fig. 5j, l,
black arrows). This is similar to models of perturbed coronary
vascular development due to increased RA signalling60,61.
By E17.5, 6/6 control E17.5 hearts had clear CD31-positive
endothelial tubes throughout the myocardium (Fig. 5m, n). By
contrast, 6/6 E17.5 ID embryos had fewer obvious endothelial
tubes in the myocardium. Instead, patches of CD31-positive cells
were visible on the surface of the heart (Fig. 5p, white arrows).
This phenotype is very similar to that of Dhrs3 null embryos with
increased RA signalling61. However, despite the abnormal
patterning of distal coronary vessels, the patterning of the
proximal coronary vessels was normal. In total, 15/16 E15.5 ID
embryos had correctly positioned coronary ostia, although 6/16
had a single additional coronary ostia unilaterally (one right and
five left), in line with the previously noted incidence in the
C57BL/6 J strain62.
In the absence of normal epicardial formation, myocardial
growth is often reduced. Fittingly, ventricular compact myocar-
dium thickness was significantly reduced in E15.5 ID embryos (P
< 0.0001, Supplementary Fig. 2a). Typically, embryos with faulty
epicardium and/or coronary vascular development die in utero
between E12.5–15.5, thus these phenotypes might further
contribute to the embryonic lethality in ID embryos in
association with the aortic arch abnormalities described above.
Finally, somite segmentation is also regulated by RA signalling.
Excess RA causes abnormalities in vertebral patterning and
delayed ossification41. We therefore examined the developing
skeletal cartilage in E14.5 embryos by alcian blue staining. In
total, 29/33 ID embryos had mild vertebral segmentation defects,
including fused lamina, missing pedicles and split vertebral bodies
(Supplementary Fig. 5d, 0/21 controls, p < 0.0001).
In summary, ID embryos have defects in a variety of tissues
that require RA signalling for normal patterning, and these
defects are similar to those in genetic models of increased RA
signalling. Thus, our data supports the hypothesis that ID results
in a wide-spread disruption of RA signalling in the developing
embryo.
Dietary supplementation mid-gestation rescues the heart and
lymphatic phenotypes. Clinically, ID in pregnant women can be
treated rapidly and effectively in many cases63. Therefore, it would
be useful to know if, and when, during pregnancy that iron sup-
plementation might rescue embryonic defects. We transferred
pregnant ID mice from low iron to normal diet (200 ppm iron)
7–9 days post mating. In each case, maternal haemoglobin levels
returned to normal by E15.5 (Supplementary Fig. 6a). Diet change
on days 8 (P= 0.1241) or 9 (P= 0.0735) had no significant effect
on the prevalence of either oedema or embryonic lethality at E15.5
(Fig. 6a). By contrast, diet change on day 7 resulted in a significant
reduction in both oedema and embryonic lethality (2/53 embryos
abnormal or dead, compared to 38/80 ID embryos, P < 0.0001; and
0/58 controls, P= 0.2257; Fig. 6a, Supplementary Fig. 6d). Fur-
thermore, 0/26 of viable E7.5-rescued embryos examined at E15.5
had heart defects (30/42 ID embryos, P < 0.0001; and 1/37 con-
trols, P= 0.5873; Supplementary Table 1), indicating a complete
rescue of the heart phenotype in these embryos. Analysis of E7.5-
rescued embryos carrying the RARE-LacZ transgene confirmed
that RA signalling levels returned to normal in the OFT of these
embryos at E9.5 (Fig. 4p, q). Iron uptake from the gut is swift,
taking only a few hours64, and is even faster in ID animals with
low hepcidin levels65. Once in the maternal bloodstream, iron is
transferred to the embryo in <6 h66. Thus, phenotypic rescue by
Fig. 4 Effects of ID on cardiac progenitors and RA signalling. a–e Comparison of expression levels of the myocyte differentiation marker MHC (green) in
sagittal sections of control (a, a’) and ID (b, b’) E9.5 mouse embryos by immunohistochemistry. Nuclei were stained with TO-PRO-3 (magenta). Location of
the SHF is indicated by brackets. (c, c’) Diagrams indicating the relative positions of the SHF (dark blue), pharyngeal endoderm (green), OFT (light blue) and
left ventricle (V, red) and left atrium (A, orange) in a sagittal section of an E9.5 embryo. Quantification of length of MHC-positive SHF (d) and number of
MHC-positive cells in the SHF (e) from control (n= 8) and ID (n= 10) embryos. f–h Comparison of expression patterns of GATA4 (green) in control (f, f’)
and ID (g, g’) E9.5 mouse embryos by immunohistochemistry. Nuclei were stained with TO-PRO-3 (magenta). Location of the SHF is indicated by brackets.
Quantification of length of GATA4-positive SHF (h) and number of GATA-4-positive cells in the SHF (i) from control (n= 8) and ID (n= 8) embryos. j–m
Comparison of RA signalling levels in control (j, l) and ID (k, m) E9.5 embryos carrying the RARE-LacZ reporter allele. j, k Sagittal sections of E9.5 embryos
stained with X-gal in wholemount. Location of the SHF is indicated by brackets. Increased and patchy staining in the OFT (black arrows) and increased staining
in the ventricle (black arrowheads) are indicated. l,m Representative 3D Amira reconstructions of X-gal staining (red) from automatically thresholded two-
channel HREM data derived from E9.5 embryos stained in wholemount. The embryos are shown in transparent grey. n–q Comparison of ß-GALACTOSIDASE
protein expression (green) by immunohistochemistry in control (n, n’), ID (o, o’) and E7.5 rescue (p, p’) E9.5 embryos carrying the RARE-LacZ reporter allele.
Nuclei were stained with TO-PRO-3 (magenta). Increased staining in the OFT and SHF (white arrowheads) and is indicated (q) Quantitation of the relative ß-
GALACTOSIDASE staining intensity in the OFT of control (n= 8), ID (n= 5) and E7.5-rescue (n= 7) embryos. Graphs show mean ± standard deviation.
Statistical significance was tested by two-sided Mann–Whitney U test (panels d, e, h, i) or one way ANOVA with Tukey’s post hoc test adjusted for multiple
comparisons (panel q). P values: 0.0013 (panel d); <0.0001 (panel e); 0.0120 (panel h); 0.0120 (panel i); 0.0014, 0.3058, 0.0298 (panel q). ns not
significant, *P < 0.05, **P < 0.01, ****P < 0.0001. Scale bar= 130 µm (a, b, f, g, n, o, p) and 95 µm (j, k).
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returning mothers to the iron-replete diet on E7.5, but not later,
suggests that the critical period of embryonic development that is
sensitive to ID is approximately E8.5. This is identical to studies of
RA exposure, where embryonic heart development is most vul-
nerable at E8.567–69. It is also broadly similar to our previous
studies of embryonic hypoxia, which showed a peak in
vulnerability of SHF cells to hypoxia at E9.55. This stage of
development is when SHF cells migrate into the OFT and when
pharyngeal arch morphogenesis takes place. It also corresponds to
the initial movement of epicardial cells to the heart’s surface70 and
the induction of lymphatic endothelial cells in the wall of the
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stage is likely to explain the rescued cardiac, lymphatic and cor-
onary vessel defects.
Dietary or pharmacological reduction of RA signalling rescues
the heart and lymphatic phenotypes. We next tested our
mechanistic hypothesis by further altering the maternal diet. RA
is produced from dietary vitamin A. It has been known since the
1930s that maternal vitamin A deficiency (VAD) disrupts
development72, and this is now known to be caused by reduced
embryonic RA signalling. We reasoned that embryos of a mother
fed a diet low in iron (leading to increased RA signalling) and
deficient in vitamin A (leading to reduced RA signalling) might
result in relatively normal levels of RA, and thus restore normal
embryonic development. Female C7BL/6 J strain mice were
weaned onto, and maintained continuously on, a diet containing
low iron (2–6 ppm) and no added vitamin A (control and ID
diets both have 15 IU/g vitamin A). As before, these mice had
significantly reduced blood haemoglobin, confirming that VAD
did not affect iron metabolism (P= 0.0005, Supplementary
Fig. 6a). These mice were mated to control C57BL/6 J males, then
maintained on the ID/VAD diet until embryo collection on E15.5.
µMRI imaging confirmed that embryos had reduced liver iron
levels (Supplementary Fig. 6i). Strikingly, only 1/27 embryos were
dead and 3/27 had oedema (Fig. 6a; Supplementary Fig. 6e). This
is a significantly lower rate of death and abnormality than ID
embryos (38/80 ID embryos, P= 0.0019), although not a com-
plete phenotypic rescue (0/58 controls, P= 0.0087). Furthermore,
only 3/25 of these embryos had heart defects, compared to 30/42
ID (P < 0.0001) and 1/37 control embryos (P= 0.1752), indicat-
ing an almost complete rescue of heart defects (Supplementary
Table 1).
To provide more evidence in support of our hypothesis, we
tested if pharmacological reduction of RA signalling was also able
to rescue the defects in ID embryos. We treated pregnant ID
C57BL/6 J mice with two 0.7 mg/kg doses of the inverse pan-
retinoic acid receptor agonist BMS 49373 on E8.5 and E9.5, and
harvested embryos at E15.5. 0/12 low dose ID embryos were dead
and 0/12 had oedema (Fig. 6a; Supplementary Fig. 6f). This is a
significantly lower rate of death and abnormality than untreated
ID embryos (38/80 ID embryos, P= 0.0009), and suggests a
significant phenotypic rescue (0/58 controls, P > 0.9999). Further-
more, only 1/12 of the low dose ID embryos had heart defects,
compared to 30/42 ID (P= 0.0001) and 1/37 control embryos (P
= 0.4337), indicating this treatment also significantly rescued the
heart defects (Supplementary Table 1). Finally, to confirm
inhibitor activity, we treated ID pregnant females with two 3.5
mg/kg doses at E8.5 and E9.5. In total, 9/9 of these embryos had
severe sub-cutaneous oedema and 8/9 had coloboma (Supple-
mentary Fig. 6g). Furthermore, 7/8 hearts analysed had common
arterial trunk (CAT). Coloboma and CAT are typical phenotypes
of high dose BMS493 treatment and a reduction of RA
signalling73,74, but were not observed in either ID embryos or
ID embryos treated with a low dose of BMS493. This confirms
that BMS493 was active in our experiments.
In conclusion, both dietary and pharmacological reduction of
RA signalling in ID embryos rescues the heart and lymphatic
defects, providing further evidence that these defects are due to
increased RA signalling.
Gene–environment interactions increase the penetrance and
expressivity of embryonic defects. In human CHD, even in
families with a known monogenic cause, there is often an array of
different cardiac defects between individuals with the same cau-
sative mutation (variable expressivity), while others with the same
mutation do not develop CHD at all (variable penetrance)75. This
suggests that CHD phenotypes are commonly affected by genetic
or environmental modifiers. Previously we have shown in mouse
that short-term gestational hypoxia is one such modifier,
increasing the prevalence and severity of heart defects in geneti-
cally susceptible embryos, as well as causing heart failure and
embryonic lethality76,77. We hypothesised that ID might cause a
similar gene–environment interaction (GxE). Two of the most
common human genetic syndromes that include CHD with
incomplete penetrance are 22q11.2 deletion syndrome78 and
Down syndrome (DS)79. In both cases, the types of heart defects
presented clinically are similar to those of the ID model. Fur-
thermore, in Tbx1 null embryos all three Cyp26 genes are
downregulated, suggesting that RA signalling may be altered in
22q11.2 deletion syndrome43. It has long been appreciated that
there is considerable variation in the severity and penetrance of
cardiovascular phenotypes in human patients with either syn-
drome. To test the hypothesis that this variation might be con-
trolled by an environmental factor such as ID, we crossed male
C57BL/6 J background mice heterozygous for either a Tbx1 null
allele80 (a model of 22q11.2 deletion syndrome), or the Dp1Tyb
duplication81 (a model of DS), with ID females and analysed
embryonic phenotypes at E15.5. In both cases, we confirmed that
maternal haemoglobin levels were significantly reduced (Tbx1 P
= 0.0277, Dp1Tyb P= 0.0035, Supplementary Fig. 6a) and that
embryos had reduced liver iron levels (Supplementary Fig. 6j, k).
There was no increase in the prevalence of embryonic death and
oedema, heart defects or aortic arch abnormalities in Tbx1+/null
ID embryos (Fig. 6b; Supplementary Table 1; Supplementary
Table 2). Thus, maternal low iron status is not likely to be a risk
factor for increasing penetrance or severity of cardiovascular
phenotypes in 22q11.2 deletion syndrome.
Similarly, E15.5 ID embryos carrying the Dp1Tyb duplication
(Dp1Tyb+ ID) had the same prevalence of death and abnorm-
ality as wild type ID control littermates (Fig. 6b, 19/27 Dp1Tyb+
ID, 15/26 wild type ID littermates, P= 0.2498). Strikingly
however, affected embryos had more severe subcutaneous
oedema, and their lymphatics were more frequently blood-filled
Fig. 5 Lymphatic and coronary vasculature development is perturbed in ID embryos. a–m Lymphatic development. a–d Comparison of NRP2, PROX1 and
CD31 expression in back skin from control (a) and ID (b) E14.5 embryos. Magnified views of the boxed areas are shown in panels a’–a”’ and b’–b”’,
respectively (see also Supplementary Fig. 5). Quantification of the average lymphatic vessel width (c) and average intervessel distance (d) in control (n=
10) and ID (n= 11) embryos. e–h Comparison of RA signalling levels in frontal sections of control (e) and ID (g) E11.5 embryos carrying the RARE-LacZ
transgene. (f, h) Magnified views of the boxed areas in (e) and (h), respectively. i–r Coronary vasculature development. Comparison of CD31 staining of
E14.5 hearts from control (i, k) and ID (j, l). Black arrows indicate endothelial nodules. Quantitation of endothelial nodule number on the dorsal (q) and
ventral (r) surfaces of control (n= 8) and ID (n= 9) hearts.m–p Comparison of CD31 (green) expression in the coronary vasculature of control (m) and ID
(o) E17.5 embryos. Nuclei were stained with TO-PRO-3 (magenta). Magnified views of the boxed areas are shown in panels (n) and (p), respectively.
White arrows indicate ectopic CD31 staining. Graphs show mean ± standard deviation. Statistical significance was tested by two-sided unpaired t-test with
Welch’s correction (panels c, r), two-sided unpaired t-test (panel d) or two-sided Mann–Whitney U test (panel q). P values: 0.0006 (panel c); 0.5299
(panel d); 0.0090 (panel q); 0.0028 (panel r). ns not significant, **P < 0.01, ***P < 0.001. Scale bar= 715 μm (a, b); 370 µm (a’–b”’); 755 µm (e, g); 95 µm
(f, h); 680 µm (i–l); 640 µm (m, o); 64 µm (n, p). CV cardinal vein, DA dorsal aorta.
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(Fig. 6d; 10/11 Dp1Tyb+ ID oedemic embryos with blood-filled
lymphatics compared to 4/11 wild type ID, P= 0.0119). In
addition, we observed craniofacial defects in surviving Dp1Tyb+
ID embryos. 10/19 of these embryos had a failure of secondary
palate fusion (1/39 wild type ID controls, P < 0.0001, Fig. 6h), and
a further 2 embryos had holoprosencephaly (Fig. 6e, j). By
contrast, only 1/18 Dp1Tyb+ control embryos was dead at E15.5,























































































Fig. 6 Phenotypic rescue and gene-environment interaction. a Phenotypic rescue. Pregnant mice were returned to iron-replete diet between E7.5-E9.5;
fed continuously on an iron and vitamin A deficient diet (ID/VAD); or fed continuously on an iron deficient diet and treated with 0.7 mg/ml BMS493 on
E8.5 and E9.5 (ID/BMS). Histograms showing the percentage of embryos that were dead, abnormal or normal at E15.5. b Investigation of
gene–environment interaction. Iron deficient (ID) and control (C) C57BL/6 J females were crossed with males carrying the Tbx1null allele (TΔ), or the
Dp1Tyb duplication (DS+). Histograms showing the percentage of embryos that were dead, abnormal or normal at E15.5. c–f Representative images of
Dp1Tyb+ control (c), wild type control ID (d), Dp1Tyb+ ID with holoprosencephaly (e), Dp1Tyb+ control (f), E15.5 embryos. g–j Dp1Tyb+ embryos from ID
mothers have craniofacial defects. Representative 3D reconstructed frontal sections of HREM data from wild type ID (g, i) and Dp1Tyb+ ID (h, j) E15.5
embryos showing examples of failed secondary palate fusion (h, yellow arrow) and holoprosencephaly (j). g’–j’ Sagittal sections from the same embryos
showing the location of the sections in (g–j) (red lines). note that panels (g) and (i) are the same control embryo. T tongue. Statistical significance was
tested using one-sided Fisher’s exact test (panel c). P values: 0.0657 (ID vs E9.5); 0.1127 (ID vs E8.5); <0.0001 (ID vs E7.5); 0.0019 (ID vs ID VAD);
0.0009 (ID vs ID BMS); < 0.0001 (C vs E9.5); <0.0001 (C vs E8.5); 0.2257 (C vs E7.5); 0.0087 (C vs ID VAD); >0.9999 (C vs ID BMS); 0.4859 (DS+ ID
vs WT ID); <0.0001 (DS+ ID vs DS+ C); 0.0321 (DS+ ID vs ID); 0.2494 (WT ID vs ID); (0.0006 DS+ C vs ID); 0.4742 (TΔ ID vs WT ID); <0.0001 (TΔ
ID vs TΔ C); 0.1000 (TΔ ID vs ID); 0.0457 (WT ID vs ID); <0.0001 (TΔ C vs ID). ns not significant, *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.
Scale bar= 2 mm (c–f); 700 µm (g, h); 1.2 mm (I, j); 1.6 mm (g’–I’).
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failure of secondary palate fusion (Fig. 6f). This induction of
previously undescribed phenotypes is an indication that we have
identified a bona fide gene–environment interaction, rather than a
simple additive effect.
We also assessed heart morphology in surviving embryos at
E15.5. 16/18 ID Dp1Tyb+ ID embryos had heart defects
(Supplementary Table 1), compared to 10/19 wild type ID
littermates (P= 0.0186) and 1/16 Dp1Tyb+ controls (P <
0.0001). Furthermore, Dp1Tyb+ ID embryos had significantly
more AVSDs (10/18) than wild type ID embryos (3/19, P=
0.0135), Dp1Tyb+ control embryos (0/16, P= 0.0003) or ID
embryos (5/42, P= 0.0008). Finally, 4/18 Dp1Tyb+ ID embryos
had type I PTA, which was never observed in wild type ID
control, Dp1Tyb+ control or wild type ID control embryos.
Thus, we conclude that maternal ID leads to an increase in the
penetrance and severity of heart defects in Dp1Tyb+mouse
embryos. By contrast, there was no change in the prevalence of
AA anomalies between Dp1Tyb+ ID and wild type ID embryos
(Supplementary Table 2).
In conclusion, ID is a substantial modifier of heart, lymphatic
and/or craniofacial phenotype in a mouse model of DS.
Discussion
Here we report a previously unknown environmental teratogen in
mice: maternal ID anaemia. Clinically, this is potentially of
importance, since anaemia is a major global health problem
affecting 38% of pregnant women, half of which is due to ID, the
most common micronutrient deficiency worldwide. We show in
mice that maternal ID causes severe embryonic cardiovascular
defects via premature differentiation of a subset of cardiac pro-
genitor cells. At the molecular level, this most likely results from
increased retinoic acid signalling. Furthermore, we show that the
defects can be rescued by iron administration early in pregnancy,
by reducing vitamin A intake in iron deficient mothers or by
treatment with an inhibitor of RA signalling. Although our results
do not formally distinguish between ID or generalised anaemia as
the cause of the defects, we believe it is more likely to be ID. The
evidence for this is three-fold. Firstly, we demonstrate that
maternal ID phenocopies embryonic loss of CYP26 activity in the
heart, coronary vessels and lymphatic system, phenotypes that in
each case result from increased embryonic RA signalling. CYP26
is an iron-dependent enzyme, therefore it is possible that ID
could partially reduce its enzymatic activity, resulting in mildly
increased RA signalling. Secondly, maternal exposure to chronic
mild hypoxia late in gestation, mimicking the effects of maternal
anaemia, causes reduced RA signalling in her offspring’s kidney
post-natally82, that is, the opposite effect to our observations.
Lastly, human epidemiological studies suggest that maternal
anaemia only increases offspring CHD risk minimally (adjusted
odds ratio (OR) 1.283–85), whereas low iron intake in the first
trimester (with or without overt anaemia) has an adjusted OR of
offspring CHD of up to 5.011. Our hypothesis that ID causes
mildly increased RA signalling is supported by studies of the
effects of exposure of pregnant mice to excess RA67–69,86. Here,
administration of low doses of RA results in the same phenotypes
as ID at E15.5, including isolated membranous VSD and DORV.
By contrast, administration of high doses of RA causes TGA,
which we do not observe in ID embryos. Furthermore, low doses
of RA also cause highly similar morphological defects to ID
earlier in development: shortening and rotational defects of the
OFT at E10.5; hypoplasia and dysplasia of the proximal OFT
cushions (but not the AVC cushions) and hypoplastic or absent
aortic ICC at E12.5;67–69 and thin ventricular myocardium at
E13.586. However, one feature of our hypothesis that is difficult to
explain is why ID has a relatively minor effect on embryogenesis.
Iron is required for the function of almost 400 human proteins87,
and one might imagine that the activities of many of these pro-
teins would also be affected in ID embryos. Why the CYP26
enzymes might be particularly sensitive to reduced iron levels in
the embryo remains unclear.
Our observations have important clinical implications. We
induce maternal ID in mice via environmental modification.
However, maternal ID can also arise from genetic insufficiency
and this could potentially have similar effects on embryonic
development. The induction of identical phenotypes in different
individuals by genetic, environmental or gene–environment
interaction is called phenocopying. This has previously been
suggested to occur in some types of human congenital abnorm-
alities, for example congenital NAD deficiency disorder88,89. Our
results suggest that some cases of CHD or craniofacial defects
might arise from maternal mutations in the almost 40 genes
required for iron transport and/or metabolism. To address how
common such mutations might be in humans, we examined the
Genome Aggregation Database90. This is an aggregate of human
exome and genome sequencing data from 141,456 individuals
without severe paediatric diseases. We identified 771 predicted
loss-of-function variants in these genes. Individuals carrying these
variants might be predisposed to developing iron deficiency, and
thus may have increased risk of having offspring with birth
defects.
Our discoveries could also explain some of the variable pene-
trance of CHD and cleft palate in children with DS91. Our
unexpected observation of a strong gene–environment interaction
in mice resulting in a failure of secondary palate fusion supports
our hypothesis that ID causes increased RA signalling. Cyp26b1
null mouse embryos have fully penetrant cleft palate92,93, and
high maternal doses of Vitamin A can also induce cleft palate in
mouse94. In addition, people with DS have an increased risk of
cleft palate95. Thus the combination of mildly increased RA due
to ID, combined with a genetic susceptibility due to DS, may
explain our results. This hypothesis is further supported by the
presence of PTA in some Dp1Tyb+ ID embryos. This phenotype
is typical of offspring of pregnant mice administered high doses
of RA67–69, but is not observed in ID alone or Dp1Tyb+ control
embryos. However, the link between Dp1Tyb and RA signalling is
not obvious. The duplicated region contains 172 protein coding
genes, of which at least three have been associated with RA sig-
nalling: Nrip1, Runx1 and Ripply3. Intriguingly, Ripply3 is a
transcriptional co-repressor of Tbx196 and is a direct target of RA
signalling97. Thus, in Dp1Tyb+ ID embryos, slightly increased
RA signalling coupled with an extra copy of Ripply3, may cause
repression of Tbx1 target genes, resulting in a phenocopy of Tbx1
null phenotypes, including cleft palate98 and more severe cardi-
ovascular defects. Finally, the clinical relevance of our
gene–environment interaction observations could be relatively
easily tested by a retrospective clinical study investigating the
phenotypes of children with DS and the peri-conception iron
status of their mothers.
Our finding that combined iron and vitamin A deficiency
substantially rescues the cardiovascular defects may explain the
disparity between animal experiments and epidemiological stu-
dies of VAD. There is very strong evidence in animal models that
VAD alone is highly teratogenic, but epidemiological studies to
date have not found a particularly strong association between
VAD and CHD. In the developing world, 15% of pregnant
women have VAD99 and these women also commonly have ID as
well. Our results might suggest that the combination of iron and
vitamin A deficiency may balance RA levels, and thus mask any
effect of VAD alone on CHD prevalence.
Studies of genetic causes of birth defects are useful on a case-
by-case basis to provide information on prognosis, treatment
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options and recurrence rate. However, understanding particular
genetic causes of birth defects has limited value in reducing their
overall birth prevalence. By contrast, our elucidation of ID as a
potential environmental risk and/or modifying factor for CHD
may guide changes in clinical advice. Current WHO and National
Institute for Health and Care Excellence (NICE) guidelines have
conflicting advice on iron supplementation during pregnancy,
with the WHO recommending daily iron supplementation to all
pregnant women, whereas NICE recommends supplementation
only in cases of substantial ID100,101. With the caveat that our
results are from work in an animal model and there are other
factors in women that would need to be taken into consideration
(for example, how infections in women may affect iron levels so
care is needed on levels of supplementation and questions on how
to monitor “safe” levels of iron in women), our results suggest
that women planning pregnancy might be advised to maintain
optimal iron levels throughout pregnancy. This conclusion is
supported by a recent study suggesting that low iron intake
during early pregnancy in humans increases the risk of offspring
CHD by up to 5-fold11.
Methods
Animals. All animal experiments were compliant with the UK Animals (Scientific
Procedures) Act 1986 and approved by the University of Oxford animal welfare
review board and the Home Office (project license PB01E1FB3). Mice were housed
in an SPF facility free from the major rodent pathogens except Helicobacter
hepaticus, with a 12:12 h light/dark cycle, at 19–23 °C, 55 ± 10% humidity, in
individually ventilated cages (Tecniplast UK Ltd, Rushden, UK) containing Grade 4
Aspen Chip bedding (Datesand Ltd, Manchester, UK), cardboard tunnels and
Sizzle Pet nesting material (LBS Biotechnology, Horley, UK), with free access to
food and tap water. Bedding was changed fortnightly, and animals were assessed
daily for welfare. Mice were fed with Teklad 2916 or TD.08713 (control), TD.99397
(iron deficient) or TD.190023 (iron and vitamin A deficient), all from Envigo,
Belton, UK. C57BL/6 J mice were purchased from Charles River UK. Genetically
modified mouse strains were; Tg(Mef2c-EGFP)#Krc (Mef2c-AHF-GFP);33 Tg
(RARE-Hspa1b/lacZ)12Jrt (RARE-LacZ);48 Dp(16Lipi-Zbtb21)1TybEmcf
(Dp1Tyb);81 and Tbx1tm1Bld (Tbx1LacZ)80. Genotyping of pups and embryos was
done by standard methods using primers listed in Supplementary Table 3. All
genetically modified mice were from colonies that had been backcrossed for more
than 10 generations onto the C57BL/6 J background, with the exception of the
RARE-LacZ strain, which was maintained on a CD-1 background. BMS493
(Merck) was dissolved at 10 mM in ethanol, then diluted in corn oil (Merck) and
0.7 or 3.5 mg/kg administered by oral gavage in the morning of E8.5 and E9.5.
Pregnant mice were sacrificed humanely, and embryos dissected in 1 x Hanks
Balanced Salt Solution+ 10 mM EDTA. Whole embryos were photographed using
a Leica M80 Stereomicroscope with a Leica DMC4500 digital camera and Leica
LAS 4.8.0 software.
Blood haemoglobin and liver iron content measurement. Blood haemoglobin
levels were measured in fresh blood using a HemoCue® Hb 201+ according to the
manufacturer’s instructions. Values of two separate samples were averaged. Two
liver samples were taken per animal at sacrifice and one snap-frozen in liquid
nitrogen, and the other fixed overnight in Formalin. Frozen samples were analysed
by inductively coupled plasma mass spectrometry (ICP-MS)102. Briefly, tissue was
digested in 1 ml 70% nitric acid (438073, Sigma) using a Discover® SP-D 80
automated microwave digestion system (CEM). Samples were analysed using a
Thermo Finnigan Element 2 Sector-Field ICP-MS. For calibration, spikes of 0, 0.5,
1, 10, 20 and 100 ng/g iron were added to replicates of a selected sample. An
external iron standard (ICP- MS-68-A solution; High Purity Standards) was diluted
and measured to confirm the validity of the calibration. Rhodium also was spiked
onto each blank, standard, and sample as an internal standard at a concentration of
1 ng/g. Concentrations from ICP-MS were normalised to starting tissue weight.
Fixed liver samples were paraffin embedded, sectioned, and stained by the DAB-
enhanced Perls method102. Briefly, slides were immersed for 1 h in 1% potassium
ferricyanide in 0.1 M HCl buffer and then stained with DAB chromogen substrate
(K3468, Dako). Slides were counterstained with hematoxylin and imaged with a
Nikon COOLSCOPE slide scanner and staining intensity was measured by colour
deconvolution with the H DAB vector in FIJI 2.0.0-rc-69/1.52p software.
Embryo and heart morphology assessment. Micromagnetic resonance imaging
(µMRI) was performed as previously described103,104, using either a Varian 9.4 T
VNMRS 20 cm horizontal-bore system (Varian Inc. Palo Alto, CA, USA) or a 11.7
T (500MHz) vertical magnet (Magnex Scientific, Oxon, UK), both running a
Varian/Agilent DDR2 console. Briefly, fixed embryos were incubated in 2 mM
Magnevist® (Bayer) and embedded in agarose in a Wilmad LabGlass 28-PP-9”
tube. Parameters for the 9.4 T system were: TR 28ms, TE 16ms, flip angle 52°, 5
averages, 27 × 27 × 27 mm3 with a matrix size of 5123, giving an isotropic resolu-
tion of 52 × 52 × 52 µm3 per voxel. A hard RF pulse (duration 100 ms) was used for
excitation and receiver bandwidth of 66 kHz. Parameters for the 11.7 T system
were: TR 16.8 ms; TE 4.5 ms; 50° flip angle (BIR-4 adiabatic); 9 averages, 24 × 24 ×
32 mm3 FOV; 1024 × 1024 × 1366 matrix size, 50 kHz bandwidth, 75% partial
Fourier scheme;105 and reconstructed with the Berkley advanced reconstruction
toolkit v0.6 (https://zenodo.org/record/3934312) as 1536 × 1536 × 2049 (complex
double) voxels with an isotropic 15.6 µm3 resolution. In all cases, µMRI was
followed by paraffin embedding, sectioning and H&E staining. High resolution
episcopic microscopy (HREM) was performed as previously described106. Briefly,
samples were fixed overnight at room temperature in Bouin’s fixative (HT10132,
Merck), then washed extensively in PBS, before dehydrated in a graded methanol
series. Samples were embedded using a JB-4 kit (Catalogue number 00226-1,
Polysciences) by overnight infiltration at 4 °C with a 50:50 mix of methanol:infil-
tration solution (JB-4 Solution A plus 1.25% (w/v) Benzoyl Peroxide Plasticizer),
washed once for 60 min at 4 °C in 100% infiltration solution, then incubated for up
to 1 week at 4 °C in fresh infiltration solution. Samples were embedded in infil-
tration solution plus 6% (v/v) JB-4 solution B to initiate polymerisation, and then
analysed using a 3D Optical high resolution episcopic microscopy imaging system
(Indigo Scientific). µMRI and HREM data were analysed using OsiriX MD DICOM
viewer version 9.0.2 (Pixmeo), Horos 3.3.6 (https://horosproject.org) and Amira for
Life & Biomedical Sciences version 2019.4 (Thermo Fisher Scientific).
RNA-Seq. In total, 1110–4566 GFP-expressing viable cells were sorted from E9.5
embryos carrying the Mef2c-AHF-GFP allele33 by FACS using a Beckman Coulter
MoFlo AstriosEQ with Summit 6.2.7.16492 software. GFP was detected with the
488 nm laser and a 513/26 band pass filter, and DAPI as a viability dye was
detected with the 405 nm laser and a 448/59 band pass filter. Cells were collected
into Eppendorf DNA LoBind tubes containing lysis buffer, and RNA isolated using
a Qiagen RNeasy Mini kit. RNA quality was assessed using RNA pico chips on an
Agilent 2100 Bioanalyzer. Library preparation (SMARTer Ultra Low Input RNA
for Illumina Sequencing - HV kit) and sequencing (Illumina HiSeq4000) were
performed by the High-Throughput Genomics Group at the Wellcome Trust
Centre for Human Genetics. The samples were processed sequenced in two bat-
ches. Batch 1 contained three control and five hypoxia samples, and batch 2
contained two repeated control samples with five ID samples.
RNA-Seq data analysis. QC of the raw sequencing reads was performed using
FastQC (https://www.bioinformatics.babraham.ac.uk/projects/fastqc). Reads were
aligned to Mus musculus genome (mm10) using the splice-aware algorithm STAR
v2.5.3a107. Gencode version M12 (Ensembl 87) was used for the annotation of the
mouse genome. The DNA sequence of the GFP vector was included in the mm10
reference and its transcript was taken into account during alignment. The R
Package Rsubread v1.32.4108 was used to assign and quantify the reads corre-
sponding to each genomic feature indicated by the mm10 Gencode transcripts.
Reads were assigned to the target that has the largest number of overlapping bases.
The minimum fraction of overlapping bases in a read that is required for read
assignment was 0.25. Counts per million (CPM) values were calculated for each
sample and genes were excluded from the analysis if they did not have a CPM of a
least 0.5 in a least 2 libraries. Normalisation was performed using trimmed mean of
values (TMM) as implemented in the edgeR v3.24.3 R package109 to scale the raw
library sizes110. Voom transformation was performed to prepare the data for linear
modelling using limma v3.38.3111,112. Principal Component Analysis and Multi-
dimensional scaling was performed for quality control to investigate sample clus-
tering. Batch correction was performed using the ComBat method113 in the sva R
v3.30.1 package114. Differential expression analysis between control and treated
samples was performed using limma v3.38.3112. Multiple testing correction was
performed on the p-values using the Benjamini-Hochberg false-discovery rate
(FDR) procedure with an FDR <5%115. Differentially expressed genes were
determined using adjusted p value < 0.01 and logFC >1 or <−1 and B > 1. Unsu-
pervised Hierarchical clustering (Fig. 3b) was performed using the Euclidian dis-
tance measure and complete agglomeration method and the pheatmap v1.0.12 R
package (https://cran.r-project.org/web/packages/pheatmap/index.html).
Immunohistochemistry, X-gal staining and RNAScope®. All antibodies used for
this study are listed in Supplementary Table 4. Immunohistochemistry on paraffin
sections was done as previously described5. Briefly, embryos were fixed overnight
in 4% paraformaldehyde at 4 °C, paraffin embedded and sectioned in the indicated
plane. To minimise inter-slide staining variation, tissue arrays were made by
putting single sections from 12–20 different embryos on a single slide, and slides
were processed using a Shandon Sequenza® Immunostaining Centre (Thermo
Fisher Scientific). For detecting ß-GALACTOSIDASE, the signal was amplified
using a peroxidase-conjugated secondary antibody and Alexa Fluor™ 488 Tyramide
SuperBoost™ Kit (Thermo Fisher Scientific). For immunohistochemistry on
wholemount hearts, tissue was fixed overnight in paraformaldehyde at 4 °C. Hearts
were washed three times in phosphate buffered saline plus 0.1% Triton X-100
(PBST), blocked in 5% goat serum in PBST for one hour at 4 °C, then incubated in
Armenian hamster anti-CD31 monoclonal antibody in PBST plus 1% bovine
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serum albumin overnight at 4 °C. Hearts were washed three times in PBST, then
incubated in biotinylated goat anti-Armenian hamster secondary antibody for 60
min at 4 °C. Hearts were washed three times in PBST, then incubated in avidin-
biotin horseradish peroxidase complex (VECTASTAIN® ABC-HRP Kit PK-4000,
Vector Laboratories) 1:50 in PBS for 30 min. Finally, hearts were washed three
times in PBST and placed in DAB substrate (Peroxidase substrate kit SK-4100,
Vector Laboratories). When staining was complete, the reaction was stopped by
washing in MilliQ water. X-gal staining of embryos in wholemount was carried out
by standard methods116. Briefly, freshly dissected embryos carrying the RARE-
LacZ allele were incubated in fix solution (0.2% glutaraldehyde, 0.1 M phosphate
buffer pH 7.3, 2 mM MgCl2, 5 mM EGTA) for 10 min a t room temperature,
washed twice in wash buffer (0.1 M phosphate buffer pH 7.3, 2 mM MgCl2, 0.1%
sodium deoxycholate, 0.02% Nonidet™ P40) and stained in stain solution (wash
solution plus 0.2 M sodium chloride, 5 mM potassium ferricyanide, 5.7 mM
potassium ferrocyanide, 1.7 mM spermidine, 1 mg/ml 5-Bromo-4-chloro-3-indo-
lyl-β-D-galactopyranoside (XGAL-RO, Merck)) for up to 60 min at room tem-
perature. Staining was stopped by washing in wash buffer, embryos fixed overnight
in 4% PFA, and embedded in paraffin prior to sectioning. Sections were imaged
using a Zeiss Discovery V8 microscope with Zeiss Zen 2012 (blue) software.
RNAScope® with the Mm-Gata4-C1 probe (Catalogue number 417881, Bio-
Techne, UK). was performed on paraffin sections using a manual RNAscope®
Multiplex Fluorescent Reagent Kit v2 (Catalogue number 323100, Bio-Techne,
UK), following the manufacturer’s instructions. The Gata4 signal was developed
using Opal™ dye 690 (FP1497001KT, Akoya Biosciences, USA) at 1:750 dilution.
After development, slides were processed for immunohistochemistry with the anti-
MF20 antibody and stained with DAPI. Slides were imaged variously on: (i) an
Olympus FV1000 or FV3000 confocal microscope with Fluoview FV31S-SW
software; (ii) a Zeiss LSM980 confocal microscope with Zen Blue 3.3 software.
Statistical analyses. All statistical analyses were performed with Prism 8.4.2
(GraphPad Software). Data were first tested for normal distribution by
Shapiro–Wilk test and equal variance by F test. For data with two groups, normally
distributed samples were tested for statistical significance using two-tailed Student’s
t test (if variances equal) or two-tailed Welch’s corrected t test (if unequal var-
iances). Non-normally distributed samples were tested using a two-tailed
Mann–Whitney U test. For data with more than two groups, normally distributed
data were tested using ANOVA followed by Tukey’s or Dunnett’s post hoc test
adjusted for multiple comparisons to compare the means of each group with every
other group. Non-normally distributed data were tested using Kruskal–Wallis one-
way ANOVA with Dunnett’s post hoc test adjusted for multiple comparisons. The
statistical significance of binomial prevalence data was tested using one-tailed
Fisher’s exact test. Data are presented as mean ± standard deviation.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
The RNA-Seq data supporting the findings of this study have been deposited in the
Sequence Read Archive (SRA) database under accession code: BioProject ID
PRJNA596545.
Source data are provided with this paper.
Other data that support the findings of this study are available from the corresponding
author upon reasonable request. Source data are provided with this paper.
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